Pain Relief Effect of Low-intensity Continuous Ultrasound St... | Clinical Trial | StuddyBuddy@endsection Pain Relief Effect of Low-intensity Continuous Ultrasound Stimulator for Knee Arthritis
Join us at Health Research Day — June 6th at Canton Waterfront Park, Baltimore!   Learn More →
← Back to all trials
Completed NCT05657535

Pain Relief Effect of Low-intensity Continuous Ultrasound Stimulator for Knee Arthritis

Conditions: Osteoarthritis, Knee

Sex: All
Healthy volunteers: 1
Phase: NA
Enrollment: 35
Sponsor: Kyu Jae Lee

Location: Korea, Republic of

Summary

The goal of this clinical trial is to test low-intensity continuous ultrasound stimulator(LICUS) for patients suffering from knee arthritis. it aims to evaluate the pain relief effect of LICUS.35 participants were recruited, treated by LICUS on the knee joint for 5 minutes, 3 times a day for 4 weeks.This study has single group and is for a before and after comparison of clinical treatment.

Eligibility Criteria

Inclusion Criteria:Patients aged 40 to 60 years with pain due to OA of the knee and able to walk voluntarilyThose who have more than one osteophyte in the tibiofemoral joint on radiographic findings (Kellgren-Lawrence gradesⅡ,Ⅲ)At visit 1 (screening) and visit 2, the pain status during knee OA activity was 100 mm pain VAS, as a result, those who are over 40mmIf the Kellgren & Lawrence Grades are the same, target the one with the higher 100mm pain VASPatients who are willing or able to follow the doctor's instructions, including joint movementsPersons who can comply with concomitantly permitted drugs, prohibited drugs, and relief drugsPersons who can maintain the same exercise and activity during the clinical trial periodFully understand the purpose and procedure of this clinical trialExclusion Criteria:Those who have a history of rheumatoid arthritis or gouty arthritis or who have peripheral pain other than the knee joint patient.Those with fractures or dislocations on simple radiological examination.Those who are identified, or those with a similar risk of neuromuscular diseaseThose who have participated in other clinical trials within 6 months of participating in clinical trials.Patients with severe pain in the knee joint other than angular deformity, instability, and index knee in the knee jointPatients with other tumors other than degenerative knee arthrosisPersons with systemic symptoms that may affect knee painPregnant and lactating women

Interested in this study? View the official listing for contact and enrollment details.

View on ClinicalTrials.gov

Source: ClinicalTrials.gov (NCT05657535). StuddyBuddy aggregates publicly available trial information.